Study on Confirmed Case of Neutropenic Enterocolitis in Armenia

T. Grigoryan, P. Ghazaryan, S. Danielyan, G. Tamamyan
{"title":"Study on Confirmed Case of Neutropenic Enterocolitis in Armenia","authors":"T. Grigoryan, P. Ghazaryan, S. Danielyan, G. Tamamyan","doi":"10.9734/bpi/tipr/v11/3603f","DOIUrl":null,"url":null,"abstract":"Neutropenic enterocolitis (NE) also known as typhlitis is a severe condition usually affecting immunocompromised patients. This is a first documented case of NE in Armenia. 12-years old girl who was diagnosed with Hodgkin Lymphoma IIA in September of 2019 was hospitalized and chemotherapy was initiated with prednisolone, vincristine, doxorubicin and etoposide. On the 9th day of chemotherapy she had abdominal pain, cramps, constipation. Laboratory findings were unremarkable. Empiric Helicobacter Pylori (HP) eradication was prescribed (regimen with amoxicillin and clarithromycin) by gastroenterologist. 2 days later she had fever and CBC showed profound neutropenia (WBC -0.34 neutrophil counts 0.06*103/\\(\\mu\\)L). Meropenem was started for febrile neutropenia. Despite the treatment symptoms were persistent. Based on the symptoms (fever, neutropenia, abdominal pain, diarrhea) NE was suspected and CT scan of abdomen was performed. It revealed the width of the intestinal mucosa 0.5-1.0 cm. Consequently, the diagnosis of NE was confirmed and clarithromycin was switched to metronidazole accordingly. Pseudomonas aeruginosa was detected in blood culture and Proteus vulgaris was detected in stool culture. After 10 days of antibacterial therapy and diet the patient was recovered. CONCLUSION: Awareness of typhlitis and possible risk factors at local institutions might help to modify the incidence and consequences of typhlitis.","PeriodicalId":165896,"journal":{"name":"Technological Innovation in Pharmaceutical Research Vol. 11","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technological Innovation in Pharmaceutical Research Vol. 11","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/tipr/v11/3603f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Neutropenic enterocolitis (NE) also known as typhlitis is a severe condition usually affecting immunocompromised patients. This is a first documented case of NE in Armenia. 12-years old girl who was diagnosed with Hodgkin Lymphoma IIA in September of 2019 was hospitalized and chemotherapy was initiated with prednisolone, vincristine, doxorubicin and etoposide. On the 9th day of chemotherapy she had abdominal pain, cramps, constipation. Laboratory findings were unremarkable. Empiric Helicobacter Pylori (HP) eradication was prescribed (regimen with amoxicillin and clarithromycin) by gastroenterologist. 2 days later she had fever and CBC showed profound neutropenia (WBC -0.34 neutrophil counts 0.06*103/\(\mu\)L). Meropenem was started for febrile neutropenia. Despite the treatment symptoms were persistent. Based on the symptoms (fever, neutropenia, abdominal pain, diarrhea) NE was suspected and CT scan of abdomen was performed. It revealed the width of the intestinal mucosa 0.5-1.0 cm. Consequently, the diagnosis of NE was confirmed and clarithromycin was switched to metronidazole accordingly. Pseudomonas aeruginosa was detected in blood culture and Proteus vulgaris was detected in stool culture. After 10 days of antibacterial therapy and diet the patient was recovered. CONCLUSION: Awareness of typhlitis and possible risk factors at local institutions might help to modify the incidence and consequences of typhlitis.
亚美尼亚中性粒细胞减少性小肠结肠炎确诊病例的研究
中性粒细胞减少性小肠结肠炎(NE)也称为斑疹伤寒,是一种严重的疾病,通常影响免疫功能低下的患者。这是亚美尼亚第一例有记录的NE病例,12岁的女孩于2019年9月被诊断患有霍奇金淋巴瘤IIA,并住院治疗,并开始使用强的松龙、长春新碱、阿霉素和依托泊苷进行化疗。在化疗的第9天,她出现了腹痛、痉挛和便秘。实验室检查结果无显著差异。胃肠病学医生开出了根除幽门螺杆菌(HP)的处方(阿莫西林和克拉霉素联合治疗方案)。2 d后发热,CBC显示深度中性粒细胞减少(WBC -0.34,中性粒细胞计数0.06*103/ \(\mu\) L),开始使用美罗培南治疗发热性中性粒细胞减少。尽管接受了治疗,但症状仍持续存在。根据症状(发热、中性粒细胞减少、腹痛、腹泻)怀疑NE,行腹部CT扫描。肠黏膜宽0.5 ~ 1.0 cm。因此,确诊为NE,并将克拉霉素改为甲硝唑。血培养检出铜绿假单胞菌,大便培养检出寻常变形杆菌。经过10天的抗菌治疗和饮食治疗,患者痊愈。结论:基层医疗机构对伤寒及可能的危险因素的认识有助于改变伤寒的发病率和后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信